141 related articles for article (PubMed ID: 22093752)
21. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM
Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189
[TBL] [Abstract][Full Text] [Related]
22. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
George M; Abraham TE
J Control Release; 2006 Aug; 114(1):1-14. PubMed ID: 16828914
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional alginate microspheres for biosensing, drug delivery and magnetic resonance imaging.
Joshi A; Solanki S; Chaudhari R; Bahadur D; Aslam M; Srivastava R
Acta Biomater; 2011 Nov; 7(11):3955-63. PubMed ID: 21784175
[TBL] [Abstract][Full Text] [Related]
24. Protein micro and nanoencapsulation within glycol-chitosan/Ca²+/alginate matrix by spray drying.
Erdinc B; Neufeld RJ
Drug Dev Ind Pharm; 2011 Jun; 37(6):619-27. PubMed ID: 21449696
[TBL] [Abstract][Full Text] [Related]
25. Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats.
Onishi H; Koyama K; Sakata O; Machida Y
Drug Dev Ind Pharm; 2010 Aug; 36(8):879-84. PubMed ID: 20345284
[TBL] [Abstract][Full Text] [Related]
26. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
[TBL] [Abstract][Full Text] [Related]
27. Tuftsin-modified alginate nanoparticles as a noncondensing macrophage-targeted DNA delivery system.
Jain S; Amiji M
Biomacromolecules; 2012 Apr; 13(4):1074-85. PubMed ID: 22385328
[TBL] [Abstract][Full Text] [Related]
28. A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres.
Zheng CH; Gao JQ; Zhang YP; Liang WQ
Biochem Biophys Res Commun; 2004 Oct; 323(4):1321-7. PubMed ID: 15451441
[TBL] [Abstract][Full Text] [Related]
29. Stabilizing effects of calcium alginate microspheres on Mycobacterium bovis BCG intended for oral vaccination.
Dobakhti F; Rahimi F; Dehpour AR; Taghikhani M; Ajdary S; Rafiei S; Rafiee-Tehrani M
J Microencapsul; 2006 Dec; 23(8):844-54. PubMed ID: 17390626
[TBL] [Abstract][Full Text] [Related]
30. Size control of calcium alginate beads containing living cells using micro-nozzle array.
Sugiura S; Oda T; Izumida Y; Aoyagi Y; Satake M; Ochiai A; Ohkohchi N; Nakajima M
Biomaterials; 2005 Jun; 26(16):3327-31. PubMed ID: 15603828
[TBL] [Abstract][Full Text] [Related]
31. Development of pH-sensitive tamarind seed polysaccharide-alginate composite beads for controlled diclofenac sodium delivery using response surface methodology.
Nayak AK; Pal D
Int J Biol Macromol; 2011 Nov; 49(4):784-93. PubMed ID: 21816168
[TBL] [Abstract][Full Text] [Related]
32. Formation of monodisperse calcium alginate microbeads by rupture of water-in-oil-in-water droplets with an ultra-thin oil phase layer.
Saeki D; Sugiura S; Kanamori T; Sato S; Ichikawa S
Lab Chip; 2010 Sep; 10(17):2292-5. PubMed ID: 20625583
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing hepatitis B surface antigen and Interleukin-2.
Eratalay A; Coşkun-Ari FF; Oner F; Ozcengīz E
J Microencapsul; 2010; 27(1):48-56. PubMed ID: 19545223
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).
Bhavsar MD; Amiji MM
J Control Release; 2007 Jun; 119(3):339-48. PubMed ID: 17475358
[TBL] [Abstract][Full Text] [Related]
35. Hydrogel nanoparticle encapsulated plasmid as a suitable gene delivery system.
Rafieei A; Riazi-Rad F; Alimohammadian MH; Gazori T; Fatemi SM; Havaskary M
Tsitol Genet; 2015; 49(2):16-20. PubMed ID: 26030969
[TBL] [Abstract][Full Text] [Related]
36. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
37. Coated whey protein/alginate microparticles as oral controlled delivery systems for probiotic yeast.
Hébrard G; Hoffart V; Beyssac E; Cardot JM; Alric M; Subirade M
J Microencapsul; 2010; 27(4):292-302. PubMed ID: 20163284
[TBL] [Abstract][Full Text] [Related]
38. Preparation and in vitro characterization of diltiazem hydrochloride loaded alginate microspheres.
Sultana Y; Mall S; Maurya DP; Kumar D; Das M
Pharm Dev Technol; 2009; 14(3):321-31. PubMed ID: 19235550
[TBL] [Abstract][Full Text] [Related]
39. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
[TBL] [Abstract][Full Text] [Related]
40. An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen.
Calija B; Cekić N; Savić S; Krajišnik D; Daniels R; Milić J
Arch Pharm Res; 2011 Jun; 34(6):919-29. PubMed ID: 21725813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
